We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News Medica 2024 AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Eclipse Surgical Changes Name to CardioGenesis

By HospiMedica staff writers
Posted on 11 Jul 2001
Eclipse Surgical Technologies (Sunnyvale, CA, USA) has changed its name to CardioGenesis Corp., the name of a company acquired by Eclipse in March 1999. The headquarters of the renamed firm are being moved to Foothill Ranch, CA (USA).

CardioGenesis developed a transmyocardial revascularization (TMR) surgical system and also a new minimally invasive version called PMR (percutaneous myocardial revascularization). PMR is a catheter-based procedure in which a cardiologist gains access to the heart through the femoral artery and then uses the company's laser to create tiny holes in the heart muscle in order to stimulate the growth of new blood vessels. The company will seek to add complementary products for the treatment of cardiovascular disease that fit well into its distribution model.

"CardioGenesis better reflects the new, expanded vision that the company has adopted,” said Michael J. Quinn, chairman and CEO of CardioGenesis. "Today, we're a revitalized company with a clearly defined mission. We are committed to becoming profitable, taking full advantage of our current products and technologies and expanding our product offering to treat a broader range of cardiovascular disease.”




Related Links:
Eclipse Surgical

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Gold Member
X-Ray QA Meter
T3 AD Pro
New
Electric Cast Saw
CC4 System
New
LED Surgical Light
Convelar 1670 LED+/1675 LED+/1677 LED+

Latest Business News

Boston Scientific Acquires Medical Device Company Intera Oncology

MEDICA 2024 to Highlight Hot Topics of MedTech Industry

Start-Ups To Once Again Play Starring Role at MEDICA 2024